Effects of exercise therapy on cardiorespiratory fitness in patients with schizophrenia

Medicine and Science in Sports and Exercise

Volumn 44, Issue 10, 2012, Pages 1834-1842

  Scheewe, Thomas W ^a   Takken, Tim ^b   Kahn, Reni S ^a   Cahn, Wiepke ^a   Backx, Frank J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiorespiratory fitness; cardiovascular exercise; mortality; physical health

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; FITNESS; HEART RATE; HUMAN; KINESIOTHERAPY; LUNG FUNCTION TEST; MALE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; SCHIZOPHRENIA;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CORONARY DISEASE; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HEART RATE; HUMANS; MALE; OXYGEN CONSUMPTION; PHYSICAL FITNESS; RESPIRATORY FUNCTION TESTS; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84866556928     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318258e120     Document Type: Article

References (43)

1. American College of Sports Medicine. American College of Sports Medicine Position Stand: the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998;30(6):975-91.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington (DC): Author; 2000. p. 426.
3. American Thoracic Society/American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211-77.
4. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry. 1992;49(8):615-23.
5. Aspenes ST, Nilsen TI, Skaug EA, et al. Peak oxygen uptake and cardiovascular risk factors in 4631 healthy women and men. Med Sci Sports Exerc. 2011;43(8):1465-73.
6. Astorino TA. Alterations in VOmax and the VO plateau with manipulation of sampling interval. Clin Physiol Funct Imaging. 2009;29(1):60-7.
7. Åstrand PO, Rodahl K, Dahl H, StrLmme SB. Textbook of Work Physiology: Physiological Bases of Exercise. 4th ed. Champaign (IL): Human Kinetics; 2003. p. 656.
8. Beebe LH, Smith K, Burk R, et al. Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disorders. Community Ment Health J. 2011;47(6):628-36.
9. Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs. 2005; 26(6):661-76.
10. Bille K, Figueiras D, Schamasch P, et al. Sudden cardiac death in athletes: the Lausanne Recommendations. Eur J Cardiovasc Prev Rehabil. 2006;13(6):859-75.
11. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212-7.
12. Bushe CJ, Taylor M, Haukka J. Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol. 2010;24(Suppl 4):17-25.
13. Christensen BK, Girard TA, Bagby RM. Wechsler Adult Intelligence Scale-Third Edition short form for index and IQ scores in a psychiatric population. Psychol Assess. 2007;19(2):236-40.
14. Cooper CB, Storer TW. Exercise Testing and Interpretation; A Practical Approach. Cambridge: Cambridge University Press; 2001. p. 278.
15. de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2-3):135-57.
16. Deimel H, Lohmann S. Physical capacity of schizophrenic patients. Rehabilitation. 1983;22(2):81-5.
17. Doherty M, Nobbs L, Noakes TD. Low frequency of the "plateau phenomenon" during maximal exercise in elite British athletes. Eur J Appl Physiol. 2003;89(6):619-23.
18. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine Position Stand: quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59.
19. Gretchen-Doorly D, Kite RE, Subotnik KL, et al. Cardiorespira-tory endurance, muscular flexibility and strength in first-episode schizophrenia patients: use of a standardized fitness assessment. Early Interv Psychiatry. 2011; doi: 10.1111/j.1751-7893.2011. 00313.x.
20. Harvey PD, Green MF, Keefe RS, Velligan DI. Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry. 2004;65(3):361-72.
21. Heggelund J, Hoff J, Helgerud J, Nilsberg GE, Morken G. Reduced peak oxygen uptake and implications for cardiovascular health and quality of life in patients with schizophrenia. BMC Psychiatry. 2011;11(1):188.
22. Heggelund J, Nilsberg GE, Hoff J, Morken G, Helgerud J. Effects of high aerobic intensity training in patients with schizophrenia: a controlled trial. Nord J Psychiatry. 2011;65(4):269-75.
23. Hermansen L, Saltin B. Oxygen uptake during maximal treadmill and bicycle exercise. J Appl Physiol. 1969;26(1):31-7.
24. Ice R. Long-term compliance. Phys Ther. 1985;65(12):1832-9.
25. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985;131(5):700-8.
26. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009; 301(19):2024-35.
27. Koivukangas J, Tammelin T, Kaakinen M, et al. Physical activity and fitness in adolescents at risk for psychosis within the Northern Finland 1986 Birth Cohort. Schizophr Res. 2010;116(2-3):152-8.
28. Kraemer WJ, Adams K, Cafarelli E, et al. American College of Sports Medicine Position Stand: progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2002;34(2):364-80.
29. Kwon JS, Choi JS, Bahk WM, et al. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled clinical trial. J Clin Psychiatry. 2006;67(4):547-53.
30. Lindamer LA, McKibbin C, Norman GJ, et al. Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophr Res. 2008;104(1-3):294-301.
31. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry. 2003;183:534-9.
32. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain:12-month data on a multimodal weight control program. J Clin Psychiatry. 2004;65(4):471-7.
33. Meyer JM, Davis VG, McEvoy JP, et al. Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. Schizophr Res. 2008;103(1-3):104-9.
34. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793-801.
35. Newcomer JW, Ratner RE, Eriksson JW, et al. A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. J Clin Psychiatry. 2009;70(4):487-99.
36. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123-31.
37. Strassnig M, Brar JS, Ganguli R. Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophr Res. 2011;126(1-3):103-9.
38. Vancampfort D, Probst M, Sweers K, et al. Eurofit test battery in patients with schizophrenia or schizoaffective disorder: reliability and clinical correlates. Eur Psychiatry. 2011. doi.org/10.1016/j. eurpsy.2011.01.009.
39. Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L. Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry. 2011;26(1):45-56.
40. Verhage F. Revised Scoring Method for Educational Level. Groningen (The Netherlands): Department of Neuropsychology, University Hospital Groningen; 1983. p. 169.
41. von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E, Jones P. Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl. 2009;(438):15-21.
42. Wildgust HJ, Beary M. Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? J Psycho-pharmacol. 2010;24(Suppl 4):37-50.
43. Wu MK, Wang CK, Bai YM, Huang CY, Lee SD. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv. 2007;58(4):544-50.